Patient and tumor characteristics.
|N: 12 (100%)|
|Mixed IDC/ILC||2 (16.6) |
|ER and/or PR positive||12 (100)|
*One patient had received neoadjuvant chemotherapy so tumor grade is not available. |
**IHC was performed first and if intermediate FISH was done.
IDC: infiltrating ductal carcinoma, ILC: infiltrating lobular carcinoma, LVI: lymphovascular invasion, ER: estrogen receptor, and PR: progesterone receptor.